Posted May. 28, 2014 at 7:12 a.m.

Premium Lock BioCryst drug scores well in trial, launches $100M stock offering

Published: 2014-05-28 07:12:52
Updated: 2014-05-28 07:12:52

BioCryst's BCX4161 BioCryst's BCX4161 Image 1 of 2 · Next Image…

BioCryst rolled out some of the best news it's had since the company headquarters moved to Durham from Alabama four years ago. The publicly traded drug company reported positive results from a major clinical trial. The firm also is seeking to raise $100 million in a stock offering....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll